Condensed Consolidated Statements Of Cash Flows (USD $) In Thousands, unless otherwise specified	9 Months Ended
	Jul. 27, 2012	Jul. 29, 2011
OPERATING ACTIVITIES:
Net income	$ 218,728	$ 157,122
Adjustments to reconcile net income to net cash (used in)/provided by operating activities:
Depreciation	63,677	63,856
Amortization	4,939	5,711
Stock-based compensation	7,735	5,288
(Gain)/loss on asset divestitures	1,043	(602)
Changes in certain assets and liabilities, net of effects of acquired businesses:
(Increase)/decrease in accounts and notes receivable	(85,276)	(60,619)
(Increase)/decrease in inventories and other assets	(60,848)	(48,041)
Increase/(decrease) in trade accounts payable and other accrued liabilities	28,703	(17,802)
Increase/(decrease) in income taxes payable	10,173	5,773
Increase/(decrease) in other deferred liabilities	7,999	3,075
Settlement of treasury lock contracts	(27,875)	0
Other	(2,833)	(8,203)
Net Cash (Used In)/Provided By Operating Activities	166,165	105,558
INVESTING ACTIVITIES:
Purchases of property, plant and equipment	(61,358)	(42,378)
Cash proceeds on disposal of assets	3,126	3,470
Acquisition of businesses, net of cash acquired	0	(30,579)
(Increase)/decrease in restricted cash	550	(4,274)
Net Cash (Used In)/Provided By Investing Activities	(57,682)	(73,761)
FINANCING ACTIVITIES:
Net proceeds from issuance of debt	396,816	0
Payment on retirement of debt	(200,000)	0
Net change in other borrowings	(42,375)	(59,719)
Net proceeds (repayments) of commercial paper	(42,975)	255,907
Proceeds from sale of treasury stock	35,246	31,567
Treasury stock purchases	(202,934)	(218,643)
Excess tax benefit from stock-based compensation	10,867	6,032
Dividends paid	(55,249)	(51,360)
Purchase of equity award shares	(7,614)	(11,454)
Net Cash (Used In)/Provided By Financing Activities	(108,218)	(47,670)
Increase/(Decrease) in Cash and Cash Equivalents	265	(15,873)
Effect of exchange rate changes on Cash and Cash Equivalents	3,046	761
Cash and Cash Equivalents at Beginning of Period	178,167	167,621
Cash and Cash Equivalents at End of Period	$ 181,478	$ 152,509